Evidence map›Paper›PMID 35155921›Full record

ArticleACS omega2022

Highly Stable Polymer Coating on Silver Nanoparticles for Efficient Plasmonic Enhancement of Fluorescence.

Ryo Kato, Mitsuhiro Uesugi, Yoshie Komatsu, Fusatoshi Okamoto, Takuo Tanaka, Fumihisa Kitawaki, Taka-Aki Yano

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 42 citations in OpenAlex.

  1. Metal-Enhanced Fluorescence of Nanocomplexes.Materials (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ryo KatoInstitute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima 770-8506, Japan.
Mitsuhiro UesugiPHC Corporation, 2131-1 Minamigata, Toon, Ehime 791-0395, Japan.
Yoshie KomatsuPHC Corporation, 2131-1 Minamigata, Toon, Ehime 791-0395, Japan.
Fusatoshi OkamotoPHC Corporation, 2131-1 Minamigata, Toon, Ehime 791-0395, Japan.
Takuo TanakaInstitute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima 770-8506, Japan.ORCID https://orcid.org/0000-0001-5714-5401
Fumihisa KitawakiPHC Corporation, 2131-1 Minamigata, Toon, Ehime 791-0395, Japan.
Taka-Aki YanoInstitute of Post-LED Photonics, Tokushima University, 2-1 Minami-Josanjima, Tokushima 770-8506, Japan.ORCID https://orcid.org/0000-0003-0063-6407
Tokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface coating of plasmonic nanoparticles is of huge importance to suppress fluorescence quenching in plasmon-enhanced fluorescence sensing. Herein, a one-pot method for synthesizing polymer-coated silver nanoparticles was developed using a functional polymer conjugated with disulfide-containing anchoring groups. The disulfides played a crucial role in covalently bonding polymers to the surface of the silver nanoparticles. The covalent bond enabled the polymer layer to form a long-term stable coating on the silver nanoparticles. The polymer layer coated was adequately thin to efficiently achieve plasmonic enhancement of fluorescence and also thick enough to effectively suppress quenching of fluorescence, achieving a huge net enhancement of fluorescence. The polymer-coated plasmonic nanoparticles are a promising platform for demonstrating highly sensitive biosensing for medical diagnostics.

Identifiers

PMID35155921
PMCPMC8829869
OpenAlexW4205690362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.